Serological response to SARS-CoV-2 vaccines in patients with multiple sclerosis in Argentina
Description
CONCLUSION: We found that MS patients that received Sputnik V or AstraZeneca vaccines for SARS-CoV-2 developed a serological response with no differences between the vaccines used.
